CN118354782A - 用于与表面活性剂联用的包含肽化合物的组合物 - Google Patents

用于与表面活性剂联用的包含肽化合物的组合物 Download PDF

Info

Publication number
CN118354782A
CN118354782A CN202380013956.2A CN202380013956A CN118354782A CN 118354782 A CN118354782 A CN 118354782A CN 202380013956 A CN202380013956 A CN 202380013956A CN 118354782 A CN118354782 A CN 118354782A
Authority
CN
China
Prior art keywords
less
compound
surfactant
peptide compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380013956.2A
Other languages
English (en)
Chinese (zh)
Inventor
中江慎一
高野隆介
唐蘅敏
樱井裕治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2022/038128 external-priority patent/WO2023063376A1/ja
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CN118354782A publication Critical patent/CN118354782A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
CN202380013956.2A 2022-05-02 2023-04-19 用于与表面活性剂联用的包含肽化合物的组合物 Pending CN118354782A (zh)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP2022075833 2022-05-02
JP2022-075833 2022-05-02
EP22192611 2022-08-29
EP22192611.6 2022-08-29
JPPCT/JP2022/038128 2022-10-12
PCT/JP2022/038128 WO2023063376A1 (ja) 2021-10-13 2022-10-12 ペプチド化合物及び界面活性剤を含む組成物
EP22200995.3 2022-10-12
PCT/JP2023/015658 WO2023214509A1 (ja) 2022-05-02 2023-04-19 界面活性剤と併用するためのペプチド化合物を含む組成物

Publications (1)

Publication Number Publication Date
CN118354782A true CN118354782A (zh) 2024-07-16

Family

ID=88646467

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380013956.2A Pending CN118354782A (zh) 2022-05-02 2023-04-19 用于与表面活性剂联用的包含肽化合物的组合物

Country Status (7)

Country Link
US (1) US20250186542A1 (https=)
EP (1) EP4406546A4 (https=)
JP (1) JPWO2023214509A1 (https=)
KR (1) KR20250002095A (https=)
CN (1) CN118354782A (https=)
TW (1) TW202406566A (https=)
WO (1) WO2023214509A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI787670B (zh) 2011-12-28 2022-12-21 日商中外製藥股份有限公司 具有環狀部之胜肽化合物及其醫藥組成物
WO2024219446A1 (ja) * 2023-04-19 2024-10-24 中外製薬株式会社 環状ペプチド化合物及び界面活性剤を含む組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH679277A5 (https=) * 1989-02-09 1992-01-31 Sandoz Ag
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
NZ328751A (en) * 1997-09-16 1999-01-28 Bernard Charles Sherman Solid medicament containing an anionic surfactant and cyclosporin
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
TW200409644A (en) * 2002-12-04 2004-06-16 Bio Max Inc Improved carrier system for cyclosporin pharmaceutical compositions
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
US9234023B2 (en) * 2010-06-24 2016-01-12 Biousian Biosystems, Inc. Glucagon-like peptide-1 glycopeptides
AU2012271691A1 (en) * 2011-06-14 2014-01-16 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
TWI787670B (zh) 2011-12-28 2022-12-21 日商中外製藥股份有限公司 具有環狀部之胜肽化合物及其醫藥組成物
CN104853749A (zh) * 2012-09-17 2015-08-19 塔瑞克斯制药有限公司 血管紧张素的口服制剂
WO2016004067A1 (en) * 2014-06-30 2016-01-07 Stealth Biotherapeutics Corp Aromatic-cationic peptide formulations, compositions and methods of use
JP7232758B2 (ja) 2017-06-09 2023-03-06 中外製薬株式会社 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ
WO2018225851A1 (ja) * 2017-06-09 2018-12-13 中外製薬株式会社 N-置換アミノ酸を含むペプチドの合成方法
PE20221323A1 (es) * 2019-11-07 2022-09-09 Chugai Pharmaceutical Co Ltd Compuesto de peptidos ciclicos que tiene accion inhibidora de kras

Also Published As

Publication number Publication date
JPWO2023214509A1 (https=) 2023-11-09
WO2023214509A1 (ja) 2023-11-09
TW202406566A (zh) 2024-02-16
US20250186542A1 (en) 2025-06-12
EP4406546A4 (en) 2025-10-08
KR20250002095A (ko) 2025-01-07
EP4406546A1 (en) 2024-07-31

Similar Documents

Publication Publication Date Title
CN118354782A (zh) 用于与表面活性剂联用的包含肽化合物的组合物
MX2011002936A (es) Formulaciones liquidas de bendamustina.
CN120897751A (zh) 含有环肽化合物和表面活性剂的组合物
EP0896823A1 (en) Improved stabilization of prostaglandin drug
EP4166133A1 (en) Composition containing peptide compound and surfactant
CN102464701B (zh) 一类新型化合物、其制备方法及用途
US20240366711A1 (en) Preparation containing cyclic peptide compound and method for producing same
JP2021165281A (ja) 特異的炎症収束性メディエーターの塩に関連する組成物及び方法
CN118591390A (zh) 含有包含聚氧乙烯结构的油性成分的化合物制剂
CN110958880B (zh) 固体分散制剂
WO2009120656A1 (en) Pharmaceutical for ocular indications
CN118176012A (zh) 包含肽化合物和表面活性剂的组合物
HK40111891A (zh) 用於与表面活性剂联用的包含肽化合物的组合物
HK40111890A (zh) 包含肽化合物和表面活性剂的组合物
AU2017308830A1 (en) Pharmaceutical formulations and their use
EP4582092A1 (en) Composition containing peptide, surfactant, and polymer
HK40111865A (zh) 含有包含聚氧乙烯结构的油性成分的化合物制剂
Kirby et al. Analogs of thyrotropin-releasing hormone using an aminoglycine-based template
HK40126562A (zh) 含有环肽化合物和表面活性剂的组合物
AU2005286161A1 (en) Stabilized leukotriene B4 (LTB4) agent pharmaceutical
CN114681391A (zh) 一种包含RORγ调节剂的药物制品
JP2010280705A (ja) プロトン駆動型トランスポーター介在型消化管吸収改善剤及びその製法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40111891

Country of ref document: HK